Poland as a leader in the biomedical sector in CEE ?

Poland as a leader in the biomedical sector in CEE ?

Ten post jest także dostępny w języku: polski

The COVID-19 pandemic has highlighted the importance of a strong domestic biomedical sector in fostering innovation. Therefore, the government proposed a resolution of the Council of Ministers on the adoption of the document “Government Plan for the Development of the Biomedical Sector for 2021-2030”. Poland’s ambition is to become a leader in the biomedical sector in Central and Eastern Europe.

The biomedical sector has been identified by the government as a strategic sector and should therefore be actively supported by the government, with implemented initiatives to coordinate activities and help create an ecosystem conducive to the development of the biomedical sector. The COVID-19 pandemic has highlighted the importance of a strong national biomedical sector that fosters innovation, early identification, analysis and monitoring of possible epidemiological threats, is patient-centered and takes into account a changing digital and technical environment.

The main goals of the plan are as follows:

  • increasing drug safety;
  • increasing patients’ access to new drugs;
  • improving patients’ health;
  • optimization of the healthcare system.

In terms of time, investment and anticipated effects, the strategy has been operationalized in four domains and eleven activities. The strategy responds to the needs of the healthcare industry, and its implementation will focus on identifying solutions with the greatest commercialization potential, and at the same time having a significant impact on improving the health of patients. The authors of the plan defined the priority directions for the development of the biomedical industry after getting acquainted with the state of the market and the current trends and proposals of the sector entities:

  • targeted / personalized medicine;
  • translational medicine, clinical trials and solutions supporting treatment effectiveness;
  • diagnostic, therapeutic and supportive tools for treatment and rehabilitation.

According to the legislator, the implementation of the plan while maintaining focus on key areas, implementing an effective management system and maintaining project selection criteria that focus on transforming projects towards solving key social problems, will allow Poland to strengthen its position in the biomedical sector in accordance with the assumed vision of its development.

The draft will be adopted by the Council of Ministers in the first quarter of 2022.

Similar Posts